Overview

Dasatinib in Polycythemia Vera

Status:
Terminated

Trial end date:
2010-08-27

Target enrollment:

Participant gender:

Summary

The purpose for conducting this research study is to determine the feasibility of using dasatinib as a treatment for polycythemia vera and to determine the optimum treatment regimen.

Phase:

Phase 2

Details

Lead Sponsor:

Weill Medical College of Cornell University

Collaborator:

Bristol-Myers Squibb

Treatments:

Dasatinib